News AxoGen, Inc.

Equities

AXGN

US05463X1063

Real-time Estimate Cboe BZX Other stock markets 02:35:16 2024-04-24 pm EDT			5-day change	1st Jan Change
6.85 ^USD	-1.72%		-1.30%	+0.29%

Mar. 08	Axogen Insider Sold Shares Worth $319,891, According to a Recent SEC Filing	MT
Mar. 08	AxoGen, Inc. Announces Executive Changes	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024	Apr. 16	GL
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024	Apr. 16	AQ
Axogen Insider Sold Shares Worth $319,891, According to a Recent SEC Filing	Mar. 08	MT
AxoGen, Inc. Announces Executive Changes	Mar. 08	CI
AxoGen Files $100 Million Mixed-Securities Shelf	Mar. 06	MT
Health Care Down After Mixed Earnings -- Health Care Roundup	Mar. 05	DJ
Transcript : AxoGen, Inc., Q4 2023 Earnings Call, Mar 05, 2024	Mar. 05
AxoGen: Q4 Earnings Snapshot	Mar. 05	AQ
AxoGen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 05	CI
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results	Mar. 05	GL
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results	Mar. 05	AQ
AxoGen, Inc. Provides Earnings Guidance for the Fiscal Year 2024	Mar. 05	CI
North American Morning Briefing : S&P 500 Futures -2-	Mar. 05	DJ
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024	Feb. 13	GL
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	Feb. 02	GL
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	Feb. 02	AQ
AxoGen Says Trial of Axoguard Nerve Cap Met Primary Endpoint of Pain Reduction	Jan. 19	MT
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap	Jan. 18	GL
Axogen, Inc. Announces Positive Topline Results from Its REPOSE Clinical Study	Jan. 18	CI
Axogen Expects Higher Q4 Revenue; CEO Plans to Retire	Jan. 04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News AxoGen, Inc.

Equities

AXGN

US05463X1063

Summary

Filters